期刊文献+
共找到168篇文章
< 1 2 9 >
每页显示 20 50 100
Hirayama disease simple presenting proximal upper extremity muscular atrophy
1
作者 林建华 《外科研究与新技术》 2011年第2期84-85,共2页
Objective To investigate the clinical features and magnetic resonance imaging (MRI) findings of patients with Hirayama disease simply presenting proximal upper extremity muscular atrophy. Methods Three patients with H... Objective To investigate the clinical features and magnetic resonance imaging (MRI) findings of patients with Hirayama disease simply presenting proximal upper extremity muscular atrophy. Methods Three patients with Hirayama disease simply 展开更多
关键词 MRI hirayama disease simple presenting proximal upper extremity muscular atrophy
下载PDF
HD肝病治疗仪对肝纤维化和肝硬化患者治疗探讨 被引量:4
2
作者 叶红军 邹兵 +2 位作者 李伏娥 钟李杰 王俊萍 《临床肝胆病杂志》 CAS 2005年第6期342-344,共3页
为探讨对慢性肝炎所致纤维化和肝硬化的有效治疗方法,采用随机对照方法,观察HD肝病治疗仪和中药穴位透入治疗93例慢性乙型病毒性肝炎肝纤维化和肝硬化患者的疗效。结果表明,治疗组患者症状改善,肝功能复常,肿大的肝脾回缩,HD肝病治疗仪... 为探讨对慢性肝炎所致纤维化和肝硬化的有效治疗方法,采用随机对照方法,观察HD肝病治疗仪和中药穴位透入治疗93例慢性乙型病毒性肝炎肝纤维化和肝硬化患者的疗效。结果表明,治疗组患者症状改善,肝功能复常,肿大的肝脾回缩,HD肝病治疗仪和中药穴位透人治疗有较好的抗肝纤维化作用。 展开更多
关键词 肝纤维化 肝硬化 肝病治疗仪 中医药疗法
下载PDF
HD组方对血透患者内皮素与降钙素基因相关肽影响的临床研究 被引量:2
3
作者 徐岩 李勇 +2 位作者 高延霞 马瑞霞 曹彩霞 《中国中西医结合肾病杂志》 2003年第5期273-275,共3页
目的 :观察中药HD组方在血液透析中对血透患者内皮素 (ET)、降钙素基因相关肽 (CGRP)的影响 ,探讨如何进一步提高尿毒症终末期维持性血透患者的透析效率和生活质量。方法 :选择终末期肾衰竭 (ESRD)患者6 6例 ,已作维持性血液透析 (HD)治... 目的 :观察中药HD组方在血液透析中对血透患者内皮素 (ET)、降钙素基因相关肽 (CGRP)的影响 ,探讨如何进一步提高尿毒症终末期维持性血透患者的透析效率和生活质量。方法 :选择终末期肾衰竭 (ESRD)患者6 6例 ,已作维持性血液透析 (HD)治疗 1年以上 ,随机分为常规治疗组 32例 ,中药治疗组 34例 ;另设正常对照组 2 0例。常规治疗组 :继续进行常规血液透析 ;中药治疗组 :在常规治疗组透析的基础上 ,将常规透析液中加入中药HD组方。并定期观察各组患者的收缩压 (SBP)、舒张压 (DBP)、内皮素 (ET)、降钙素基因相关肽 (CGRP) ,疗程均为 6个月。结果 :治疗 6个月后 ,中药治疗组与治疗前及常规治疗组相比SBP、DBP、ET水平显著降低 (P <0 .0 1) ,而CGRP水分显著增高 (P <0 .0 5 )。结论 :HD组方的应用可通过改善血循环状态 ,调节患者ET、CGRP代谢失衡状况 ,从而调节血管舒、缩功能 。 展开更多
关键词 hd组方 血透患者 内皮素 降钙素基因相关肽 影响 临床研究 中药透析液
下载PDF
HFHD与HD治疗在ESRD患者中的疗效及生存率比较 被引量:5
4
作者 陈小琳 慕婷 雷洁 《川北医学院学报》 CAS 2019年第5期622-624,共3页
目的:对比分析高通量血液透析(HFHD)与血液透析(HD)在终末期肾病(ESRD)中的临床疗效及其对心脏功能、生存率的影响。方法:回顾性分析120例ESRD患者的临床资料,将患者分为观察组(HFHD治疗)和对照组(HD治疗),每组各60例。比较两组患者治... 目的:对比分析高通量血液透析(HFHD)与血液透析(HD)在终末期肾病(ESRD)中的临床疗效及其对心脏功能、生存率的影响。方法:回顾性分析120例ESRD患者的临床资料,将患者分为观察组(HFHD治疗)和对照组(HD治疗),每组各60例。比较两组患者治疗前后的血清尿素氮(BUN)、肌酐(SCr)、β2-微球蛋白(β2-MG)和全段甲状旁腺激素(iPTH)水平、心脏功能及生存率。结果:治疗后,观察组患者的血清中BUN、SCr、iPTH和β2-MG水平低于治疗前(P<0.05);对照组患者的血清BUN、SCr水平低于治疗前(P<0.05);治疗后,观察组的血清iPTH和β2-MG水平均低于对照组,差异具有统计学意义(P<0.05)。治疗后,观察组的LVEF及E/A值高于对照组(P<0.05)。结论:HFHD治疗对ESRD患者血液内各毒素的清除能力较突出,同时可显著改善患者的心脏功能。 展开更多
关键词 高通量血液透析 血液透析 终末期肾病 心脏功能
下载PDF
二维超声联合四维彩超HD-flow彩色血流显像在产前诊断先天性心脏发育异常中的应用 被引量:15
5
作者 谢许萍 马小燕 +4 位作者 胡燕芳 张富 桑颖 杨晓君 张胜林 《海南医学》 CAS 2019年第19期2531-2535,共5页
目的探讨二维超声联合四维彩超超高细微分辨血流技术(HD-flow)彩色血流显像在产前诊断先天性心脏发育异常中的临床应用价值。方法选取2016年7月至2018年2月在小榄人民医院行产前超声检查并分娩的单胎妊娠孕妇2 200例,先对所有入组的孕... 目的探讨二维超声联合四维彩超超高细微分辨血流技术(HD-flow)彩色血流显像在产前诊断先天性心脏发育异常中的临床应用价值。方法选取2016年7月至2018年2月在小榄人民医院行产前超声检查并分娩的单胎妊娠孕妇2 200例,先对所有入组的孕妇进行二维超声检查,二维超声检查提示胎儿疑似宫内心脏发育异常的孕妇再联合应用四维彩超HD-flow彩色血流显像进行检查。将进行二维超声的检查结果作为对照组,将二维超声+四维彩超HD-flow彩色血流显像的检查结果作为研究组,将出生后新生儿的心脏超声诊断结果或引产后胎儿心脏病理诊断结果作为金标准。观察所有入组孕妇中胎儿先天性心脏发育异常(FCHD)的检出情况,比较不同检查方式诊断FCHD胎儿的准确率。结果2 200例胎儿经随访诊断证实有56例胎儿存在先天性心脏发育异常,占所有入组胎儿总数的2.5%(56/2 200),其中,动脉弓畸形6例,三尖瓣畸形3例,完全性大动脉转位4例,右室双出口4例,单心室(房)4例,法洛四联症(TOF)8例,心内膜垫缺损4例,单纯性室间隔缺损9例、左心发育不良4例,肺动脉瓣闭锁5例,肺动脉瓣狭窄2例,永存动脉干3例;二维超声共检查出42例FCHD,有14例误诊或漏诊,准确率为75.0%,二维超声+四维彩超HD-flow彩色血流显像检查共查出52例FCHD,误诊或漏诊4例,准确率为92.8%,研究组的准确率高于对照组,差异具有统计学意义(P<0.05);研究组的灵敏度为92.1%、特异度为94.5%,对照组的灵敏度为60.7%、特异度为90.3%,研究组的灵敏度及特异度明显高于对照组,差异均有统计学意义(P<0.05)。结论二维超声联合四维彩超HD-flow彩色血流显像检查能显著提高FCHD的产前诊断准确率,具有较高的灵敏度及特异度,值得临床推广应用。 展开更多
关键词 二维超声 四维彩超 超高细微分辨血流技术 产前诊断 先天性心脏发育异常 灵敏度 特异度 准确率
下载PDF
A New Multi-Agent Feature Wrapper Machine Learning Approach for Heart Disease Diagnosis 被引量:5
6
作者 Mohamed Elhoseny Mazin Abed Mohammed +5 位作者 Salama A.Mostafa Karrar Hameed Abdulkareem Mashael S.Maashi Begonya Garcia-Zapirain Ammar Awad Mutlag Marwah Suliman Maashi 《Computers, Materials & Continua》 SCIE EI 2021年第4期51-71,共21页
Heart disease(HD)is a serious widespread life-threatening disease.The heart of patients with HD fails to pump sufcient amounts of blood to the entire body.Diagnosing the occurrence of HD early and efciently may preven... Heart disease(HD)is a serious widespread life-threatening disease.The heart of patients with HD fails to pump sufcient amounts of blood to the entire body.Diagnosing the occurrence of HD early and efciently may prevent the manifestation of the debilitating effects of this disease and aid in its effective treatment.Classical methods for diagnosing HD are sometimes unreliable and insufcient in analyzing the related symptoms.As an alternative,noninvasive medical procedures based on machine learning(ML)methods provide reliable HD diagnosis and efcient prediction of HD conditions.However,the existing models of automated ML-based HD diagnostic methods cannot satisfy clinical evaluation criteria because of their inability to recognize anomalies in extracted symptoms represented as classication features from patients with HD.In this study,we propose an automated heart disease diagnosis(AHDD)system that integrates a binary convolutional neural network(CNN)with a new multi-agent feature wrapper(MAFW)model.The MAFW model consists of four software agents that operate a genetic algorithm(GA),a support vector machine(SVM),and Naïve Bayes(NB).The agents instruct the GA to perform a global search on HD features and adjust the weights of SVM and BN during initial classication.A nal tuning to CNN is then performed to ensure that the best set of features are included in HD identication.The CNN consists of ve layers that categorize patients as healthy or with HD according to the analysis of optimized HD features.We evaluate the classication performance of the proposed AHDD system via 12 common ML techniques and conventional CNN models by using across-validation technique and by assessing six evaluation criteria.The AHDD system achieves the highest accuracy of 90.1%,whereas the other ML and conventional CNN models attain only 72.3%–83.8%accuracy on average.Therefore,the AHDD system proposed herein has the highest capability to identify patients with HD.This system can be used by medical practitioners to diagnose HD efciently。 展开更多
关键词 Heart disease machine learning multi-agent feature wrapper model heart disease diagnosis hd cleveland datasets convolutional neural network
下载PDF
Factors contributing to clinical picture and progression of Huntington's disease 被引量:2
7
作者 Daniel Zielonka 《Neural Regeneration Research》 SCIE CAS CSCD 2018年第8期1364-1365,共2页
Huntington’s disease(HD)is an autosomal dominant,monogenic,progressive,neurodegenerative and rare disease with a frequency of10 per 100,000 in the Caucasian population and occurring more rarely in other races(Squi... Huntington’s disease(HD)is an autosomal dominant,monogenic,progressive,neurodegenerative and rare disease with a frequency of10 per 100,000 in the Caucasian population and occurring more rarely in other races(Squitieri et al.,1994).HD is,nevertheless,one of the most frequently and extensively studied diseases of those caused by a dynamic mutation.The HD mutation is located on the short arm of the 4th chromosome within the HTT gene. 展开更多
关键词 hd Factors contributing to clinical picture and progression of Huntington’s disease
下载PDF
免疫组化法和NADPH-d酶组化法在术中快速诊断婴幼儿先天性巨结肠(HD)中应用价值的比较 被引量:4
8
作者 任智慧 赵淑君 +1 位作者 阿米娜·哈山 李鸿岩 《新疆医科大学学报》 CAS 2020年第4期430-433,共4页
目的探讨免疫组化与还原型尼克酰胺腺嘌呤二核苷酸脱氢酶(NADPH-d)酶组织化学染色法在术中快速诊断婴幼儿先天性巨结肠(Hirschsprung′s disease,HD)中的应用价值及其临床意义。方法标本采自经HE常规染色确诊的36例先天性巨结肠患儿的... 目的探讨免疫组化与还原型尼克酰胺腺嘌呤二核苷酸脱氢酶(NADPH-d)酶组织化学染色法在术中快速诊断婴幼儿先天性巨结肠(Hirschsprung′s disease,HD)中的应用价值及其临床意义。方法标本采自经HE常规染色确诊的36例先天性巨结肠患儿的术中切除肠管,其中男性28例,女性8例,年龄均为3个月以内,中位年龄为2个月。标本分扩张段和痉挛段,经连续切片分别用免疫组化染色和NADPH-d染色并进行配对比较研究,观察组织蛋白酶D(cathepsin D,CAD)和NADPH-d的染色特点。结果(1)免疫组化CAD染色中,35例HD扩张段和阳性对照的肠壁黏膜下及肌间神经丛内可见阳性的神经节细胞;NADPH-d酶组织染色中35例HD扩张段和阳性对照的肠壁肌间神经丛中可见蓝色的神经节细胞;(2)免疫组化CAD染色与NADPH-d染色36例HD痉挛段组肠壁神经丛中缺乏阳性表达,未见神经丛及阳性神经节细胞;(3)免疫组织化学法和NADPH-d酶组织化学法阳性率差异无统计学意义(P>0.05),但NADPH-d法在诊断时间和辨识度比免疫组化有优势。结论NADPH-d染色法对诊断婴幼儿先天性巨结肠有优越性,NADPH-d法与其联合快速HE染色法能提高术中诊断效率,准确指示病变肠段切除范围;免疫组化实验要求高,诊断时间相对长,不适用于快速诊断婴幼儿HD。 展开更多
关键词 先天性巨结肠 快速诊断 婴幼儿 免疫组化 CAD NADPH-d染色
下载PDF
Molecular Analysis of the Huntington's Disease with Expanded CAG Trinucleotide Repeat in Chinese
9
作者 Zeng Yitao Mao Yuehua Chen Meijue Ren Zhaorui Zhou Gang Huang Shuzhen (Shanghai Institute of Medical Genetics,Shanghai Children’s Hospital,Shanghai 200040,P.R.China) Wang Xiuying~① Yie Wenghu~② Zhao Xiangzhi~③ (①Xuzhou Medical College,Xuzhou,JiangSu,P.R.China) (②Anhui Medical University,Aanhui,P.R.China) (③Henan Psychiatrical Institute,Zhengzhou,P.R.China) 《High Technology Letters》 EI CAS 1995年第1期5-9,共5页
The polymorphic CAG repeats in the IT15 gene in Chinese normal and Huntington’s dis-ease(HD)chromosomes were determined by using nested PCR and denaturing polyacry-lamide gel electrophoretic autoradiography as well a... The polymorphic CAG repeats in the IT15 gene in Chinese normal and Huntington’s dis-ease(HD)chromosomes were determined by using nested PCR and denaturing polyacry-lamide gel electrophoretic autoradiography as well as direct sequencing analysis.A total of40 normal individuals and 122 members of 13 unrelated HD families originating from Shang-hai,Jiangsu,Zhejiang,Anhui,Shandong,Guangdong and Henan,respectively,were in-volved in this study.The results showed that the(CAG)n repeat numbers in 270 normal al-leles ranged from 13 to 26 but most in 16;while in 54 HD alleles,the CAG repeats from 40to 94,with an unstable inheritance of expanded repeats in some families.There was no over-lap between the normal and affected alleles.Additionally,the presymptomatic diagnosis in103 family members at risk for HD disclosed that 35 individuals had HD alleles,which were-in accordance with the pedigree analysis and clinical investigation.All these results indicatedthat the dynamic mutation in IT15 gene was responsible for the genetic defect in the ChineseHD patients and that a correlation existed between the numbers of(CAG)n repeat and theonset age of the disease.All-of these provide valuable data for HD molecular diagnosis,ge-netic counselling and genetic health. 展开更多
关键词 Huntington’s disease (hd) IT15 GENE TRINUCLEOTIDE repeat.
下载PDF
Can leukocyte telomere shortening be a possible biomarker to track Huntington’s disease progression?
10
作者 Elide Mantuano Martina Peconi Daniela Scarabino 《Neural Regeneration Research》 SCIE CAS CSCD 2019年第10期1709-1710,共2页
Huntington's disease (HD): HD is an autosomal dominant neurodegenerative disease, caused by a CAG trinucleotide repeat expansion in the first exon of the HTT gene encoding the huntingtin protein. The mutant protei... Huntington's disease (HD): HD is an autosomal dominant neurodegenerative disease, caused by a CAG trinucleotide repeat expansion in the first exon of the HTT gene encoding the huntingtin protein. The mutant protein contains an expanded polyglutamine sequence that confers a toxic gain-of-function and causes neurodegeneration. Moreover, several studies indicate that loss of the normal protein beneficial functions, contribute to the pathology (Schulte and Littleton 2011). Triplet expansion over 40 repeats are fully penetrant and invariably lead to manifest HD in the fourth or fifth decade of life. 展开更多
关键词 Huntington's disease(hd) NEURODEGENERATIVE disease FIFTH decade of life
下载PDF
Literature Review of the Outcome after One-Stage Transanal Endorectal Pull-Through Procedure for Hirschsprung’s Disease in Children 被引量:1
11
作者 Irene Ortiz-Rubio Maria Perez-Aguilera +2 位作者 Christina Graneli Pernilla Stenstrom Einar Arnbjornsson 《Surgical Science》 2013年第5期258-262,共5页
Background: Transanal endorectal one-stage pull-through (TERPT) procedure in children with Hirschsprung’s disease (HD) is frequently used worldwide. In order to give the families realistic expectations and to plan th... Background: Transanal endorectal one-stage pull-through (TERPT) procedure in children with Hirschsprung’s disease (HD) is frequently used worldwide. In order to give the families realistic expectations and to plan the medical care for the years after TERPT, the long term outcome is of great importance. Aim: To collect information on the long term outcome reported after one stage TERPT procedure for HD in children 0 - 15 years. Method: A literature review on the outcome of planned TERPT from 2005 through 2012 was carried out. Information was collected on the number of daily stools a few months postoperatively, incontinence and constipation and the measures taken to deal with these. Results: The reports are few and prospective studies were missing. The results show an initial high frequency of daily stools, 12% had later abnormal stool patterns, 21% had fecal incontinence and 10% had problems with constipation. Conclusion: In order to compare the long term outcome, it would be desirable to have uniform regular reports on the daily frequency of passed stools, incontinence and constipation during the first years after TERPT. Such knowledge would be of importance for the information given to the guardians of children with HD preoperatively to TERPT and in the planning of the future care. The findings can, furthermore, provide a benchmark for the outcome from a single centre. 展开更多
关键词 Transendorectal Pull-Through(TERPT) Hirschsprung’s disease(hd) OUTCOME INCONTINENCE CONSTIPATION
下载PDF
National Institutes of Health Funding for disease categories related to Neural Regeneration Research
12
《Neural Regeneration Research》 SCIE CAS CSCD 2011年第26期2053-2080,共28页
The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation's medical research agency-making important discoveries that improve health and save lives.Thanks in... The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation's medical research agency-making important discoveries that improve health and save lives.Thanks in large part to NIH-funded medical research, Americans today are living longer and healthier. Life expectancy in the United States has jumped from 47 years in 1900 to 78 years as reported in 2009, and disability in people over age 65 has dropped dramatically in the past 3 decades. In recent years, nationwide rates of new diagnoses and deaths from all cancers combined have fallen significantly. 展开更多
关键词 NS NEI National Institutes of Health Funding for disease categories related to Neural Regeneration Research CTR hd NCI DC NIH ATP DE
下载PDF
Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease
13
作者 Alba Di Pardo Vittorio Maglione 《Neural Regeneration Research》 SCIE CAS CSCD 2017年第9期1439-1440,共2页
Huntington's disease (HD) is the most common dominantly inherited neurodegenerative disorder, mainly characterized by the progressive striatal and cortical neurodegeneration and as- sociated motor, cognitive and be... Huntington's disease (HD) is the most common dominantly inherited neurodegenerative disorder, mainly characterized by the progressive striatal and cortical neurodegeneration and as- sociated motor, cognitive and behavioural disturbances (Zuccato et al., 2010). The disease-causing mutation is an expansion of a GAG trinucleotide repeat (〉 36 repeats) encoding a polygluta- mine stretch in the N-terminal region ofhuntingtin (Htt) (Zuc- cato et al., 2010), a ubiquitous protein whose function is still unclear (Zuccato et al., 2010). Expansion of the polyQ stretch endows mutant Htt (mHtt) with toxic properties, and results in the development of a broad array of undesirable effects in both neuronal and non-neuronal cells (Zuccato et al., 2010). Among all cellular dysfunctions and biochemical imbalances classically associated with HD, perturbed metabolism of (glyco) sphingolipids appears to play a crucial role in the pathogenesis of the disease. Over the last years, we and other have extensively contributed to these findings (Desplats et al., 2007; 展开更多
关键词 Glyco-sphingo biology a novel perspective for potential new treatments in Huntington’s disease hd
下载PDF
Histone methylation in Huntington's disease:are bivalent promoters the critical targets?
14
作者 Nóra Zsindely László Bodai 《Neural Regeneration Research》 SCIE CAS CSCD 2018年第7期1191-1192,共2页
Huntington’s disease(HD)is a currently incurable,late onset,progressive,ultimately fatal neurological disorder(Bates et al.,2015).We have recently published the results of comprehensive genetic interaction tests ... Huntington’s disease(HD)is a currently incurable,late onset,progressive,ultimately fatal neurological disorder(Bates et al.,2015).We have recently published the results of comprehensive genetic interaction tests aimed at identification of histone methyltransferases and demethylases involved in HD pathogenesis in a Drosophila model of the disease(Song et al.,2018). 展开更多
关键词 Histone methylation in Huntington’s disease:are bivalent promoters the critical targets PRC hd MLL
下载PDF
平山病1例临床诊疗经验总结
15
作者 王楠 巩婷 +1 位作者 米改香 薛安宁 《实用中医内科杂志》 2023年第1期36-38,158,共4页
平山病(hirayama disease,HD)又称青少年上肢远端肌萎缩症,1959年由日本学者平山惠造(Keizo Hirayama)首次报道的一类具有自限性的良性运动神经元疾病。早期临床表现与脊髓性肌萎缩症(SMA)、肌萎缩型颈椎病(CSA)以及肌萎缩侧索硬化(ALS... 平山病(hirayama disease,HD)又称青少年上肢远端肌萎缩症,1959年由日本学者平山惠造(Keizo Hirayama)首次报道的一类具有自限性的良性运动神经元疾病。早期临床表现与脊髓性肌萎缩症(SMA)、肌萎缩型颈椎病(CSA)以及肌萎缩侧索硬化(ALS)等运动神经元疾病相似,但预后截然不同。文章报道甘肃省中医院脑病二科收治的1例平山病患者,并进行相关文献复习,旨在提高临床医生对该病的早期诊断和有效干预水平。 展开更多
关键词 平山病 运动神经元疾病 肌萎缩 病例报告
下载PDF
针灸治疗平山病1例
16
作者 卢琳 王安琦 +3 位作者 梁小婷 李晨 吴思平 陈秀华 《四川中医》 2023年第10期73-77,共5页
平山病是一种自限性运动神经元病,其好发于青少年,主要表现为上肢远端进行性肌无力和肌萎缩,并以骨间肌、小鱼际肌及前臂尺侧肌肉为著,由于本病起因复杂,表现各异,临床容易漏诊、误诊,目前西医治疗方法主要为佩戴颈托或手术治疗。本篇... 平山病是一种自限性运动神经元病,其好发于青少年,主要表现为上肢远端进行性肌无力和肌萎缩,并以骨间肌、小鱼际肌及前臂尺侧肌肉为著,由于本病起因复杂,表现各异,临床容易漏诊、误诊,目前西医治疗方法主要为佩戴颈托或手术治疗。本篇介绍运用针灸治疗平山病1例,以“阴阳互济、通调和畅”为主要治疗思想,以“温阳益气、清热祛湿,化瘀通络”为法。在本病治疗上,应辨证分经论治,重视调理脾胃肝肾,清泻湿热瘀阻,同时亦应疏调温煦病变局部经气,调畅气血、阴阳互济,以使经脉得养,如此才能获得满意疗效。 展开更多
关键词 平山病 上肢痿证 传统疗法
下载PDF
肝病治疗仪治疗代谢综合征合并非酒精性脂肪肝的疗效观察
17
作者 王宠雯 卢秉久 《锦州医科大学学报》 CAS 2023年第6期56-61,共6页
目的观察HD肝病治疗仪治疗代谢综合征(metabolic syndrome,MetS)合并非酒精性脂肪肝(non-alcoholic fatty liver disease,NAFLD)的疗效。方法纳入2022年1月至2022年6月于辽宁中医药大学附属医院就诊的93例MetS合并NAFLD患者作为研究对象... 目的观察HD肝病治疗仪治疗代谢综合征(metabolic syndrome,MetS)合并非酒精性脂肪肝(non-alcoholic fatty liver disease,NAFLD)的疗效。方法纳入2022年1月至2022年6月于辽宁中医药大学附属医院就诊的93例MetS合并NAFLD患者作为研究对象,随机分为对照组、用药组及治疗仪组各31例。所有患者均进行改善生活习惯等常规治疗。在此基础上用药组予水飞蓟宾胶囊70 mg日3次口服;治疗仪组予水飞蓟宾胶囊70 mg日3次口服、HD肝病治疗仪30 min日2次,每周5~7 d治疗。对照组治疗时间、用药组治疗时间、治疗仪组治疗时间均为连续4 w。对比各组治疗前后ALT、AST、GGT、TC、TG、HDL-C、FBG、PBG-2h、HbA1c、INS、HOMA-IR指数、UA的水平变化。结果各组治疗前肝功能、血脂、血糖、尿酸相关指标比较,P>0.05。各组治疗后各指标水平与治疗前相比均有降低,P<0.05。治疗后用药组及治疗仪组指标水平明显低于治疗后对照组P<0.05,治疗后治疗仪组血脂、血糖、尿酸指标水平低于用药组,P<0.05,治疗后治疗仪组肝功能指标水平低于用药组,P>0.05。对照组总有效率51.60%,共16例;用药组总有效率71.00%,共22例;治疗仪组总有效率90.32%,共2例痊愈病例,共26例有效病例;总有效率治疗仪组显著高于对照组及用药组,以P<0.05为差异具有统计学意义。结论MetS合并NAFLD对HD肝病治疗仪疗效反馈良好。 展开更多
关键词 代谢综合征 非酒精性脂肪肝 hd肝病治疗仪
下载PDF
平山病4例临床和影像学分析 被引量:20
18
作者 许蕾 黄勃源 +3 位作者 李彩英 刘亚玲 郭艳苏 李春岩 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2006年第1期23-26,共4页
目的探讨平山病的临床特征、影像学特点及发病机制。方法对4例患者的临床、神经电生理、影像学资料进行分析。颈部屈曲位,采用平卧位时骨盆下放置一个定制的楔形物而获得。结果4例均为青春期男性。主要表现为局限于手和前臂的肌萎缩,尺... 目的探讨平山病的临床特征、影像学特点及发病机制。方法对4例患者的临床、神经电生理、影像学资料进行分析。颈部屈曲位,采用平卧位时骨盆下放置一个定制的楔形物而获得。结果4例均为青春期男性。主要表现为局限于手和前臂的肌萎缩,尺侧肌肉萎缩较重,上肢呈斜坡样。4例手指伸展时出现震颤;3例伴寒冷麻痹。常规颈MR均可见颈髓下段轻度萎缩,均未发现髓内异常信号。屈颈MR均见下段颈髓前移、变平,硬脊膜向前移位;硬脊膜外间隙增宽;硬脊膜外间隙内半月形信号影,在T1加权像与脊髓的信号相同,在T2加权像呈高信号,其中有一些弧线形或圆形的血管流空信号。结论屈颈位MR,出现下颈髓及其硬膜囊的异常表现是平山病的一个显著特点,当遇到青少年(尤其是男性)出现手及前臂不对称的肌无力和萎缩时,应进一步行屈颈MR检查。 展开更多
关键词 平山病 肌萎缩 屈性脊髓病 影像学分析
下载PDF
平山病外科治疗的中期临床效果及影像学结果 被引量:9
19
作者 孙宇 刘鑫 +9 位作者 樊东升 傅渝 潘胜发 张凤山 张立 王少波 刁垠泽 陈欣 周非非 赵衍斌 《北京大学学报(医学版)》 CAS CSCD 北大核心 2017年第6期1019-1026,共8页
目的:回顾性分析应用颈前路融合内固定术治疗平山病的中期临床及影像学结果,探讨外科治疗的意义和价值。方法:36例平山病患者采用颈椎前路融合钛板内固定术治疗,观察术后3个月、1年、2年时肌肉萎缩和肌力变化,测量术后C2-7颈椎活动度的... 目的:回顾性分析应用颈前路融合内固定术治疗平山病的中期临床及影像学结果,探讨外科治疗的意义和价值。方法:36例平山病患者采用颈椎前路融合钛板内固定术治疗,观察术后3个月、1年、2年时肌肉萎缩和肌力变化,测量术后C2-7颈椎活动度的改变及C4-7节段中立位颈椎MRI横断面脊髓面积的改变。结果:(1)临床结果:除1例患者外,所有患者术后肌肉萎缩和肌无力无继续进展。随着时间推移,自觉肌无力改善的患者比例逐年增高:术后3个月为26.5%,术后1年为36.0%,术后2年时有85.7%的患者感觉肌力增加;同时肌萎缩改善的患者比例也逐年增高:术后3个月为8.8%,术后1年为24.0%,术后2年时有35.8%的患者感觉肌萎缩好转。截至术后2年随访时段时,14例患者中有12例受累肌力改善,5例肌肉萎缩得到不同程度改善。(2)影像学结果:C2-7颈椎活动度术后较术前显著减小,由术前平均62.25°±2.10°减少为术后2年时平均13.67°±7.51°(P<0.01)。屈曲位MRI脊髓不再受到压迫。颈椎各个节段MR横断面积:术后3个月时仅C6一个节段的面积较术前增大(P<0.05);术后1年时C4-5-6三个节段面积均较术前增大(均为P<0.01);术后2年时C4-5-6-7四个节段面积均较术前增大,其中C4脊髓面积增大15.60%、C5增大19.08%、C6增大21.60%、C7增大23.91%,与术前相比差异均具有统计学意义(P<0.05)。结论:前路内固定植骨融合术是治疗平山病的有效方法,可以获得较好的中期临床转归和影像学结果,对于控制平山病的发展和转归有着积极的意义和价值。 展开更多
关键词 平山病 内固定融合术 疗效 影像学
下载PDF
平山病的动态磁共振成像研究 被引量:13
20
作者 裴新龙 韩鸿宾 +2 位作者 谢敬霞 宋国军 付瑜 《中国医学影像技术》 CSCD 北大核心 2006年第8期1255-1257,共3页
目的通过颈椎中立位及过屈位磁共振扫描观察平山病患者颈髓形态的变化,进一步分析平山病诊断的影像学依据,并初步探讨平山病的发病机制。方法选择正常人无颈椎病史30例,以及确诊平山病患者20例,进行颈椎中立位及过屈位磁共振扫描,选择C... 目的通过颈椎中立位及过屈位磁共振扫描观察平山病患者颈髓形态的变化,进一步分析平山病诊断的影像学依据,并初步探讨平山病的发病机制。方法选择正常人无颈椎病史30例,以及确诊平山病患者20例,进行颈椎中立位及过屈位磁共振扫描,选择C6水平分别在两种体位测量颈髓正中线前后径,另外测量过屈位相邻两个椎体后缘的角度。结果患者C6水平颈髓前后径中立位(Dn)及过屈位(Df)分别为(0.542±0.076)cm、(0.418±0.067)cm,正常对照Dn及Df分别为(0.670±0.049)cm、(0.595±0.047)cm,患者均较正常人小(P<0.01),且过屈位颈髓前后径患者较正常人变小更为明显,且以一侧变扁为著(P<0.01)。过屈位相邻椎体后缘成角依次为AC34(3.0±2.0)°、AC45(6.7±2.2)°、AC56(11.8±2.3)°、AC67(8.6±3.7)°,下颈段大于上颈段(AC56>AC67>AC45>AC34)。结论磁共振成像可以明确显示平山病形态学改变,是诊断平山病的重要依据之一,下颈段颈椎成角较大,可能是造成平山病集中在下颈段脊髓的原因之一。 展开更多
关键词 平山病 磁共振成像
下载PDF
上一页 1 2 9 下一页 到第
使用帮助 返回顶部